Bentong Yu

Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

Jun Liu, Yang Yang, Zhichao Liu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Robot-assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma

Yang Yang, Bin Li, Jun Yi et al. · Annals of Surgery · 2021 · 194 citations

Medicine, Surgery, General Surgery +15

TRIM59 regulates autophagy through modulating both the transcription and the ubiquitination of BECN1

Tianyu Han, Meng Guo, Mingxi Gan et al. · Autophagy · 2018 · 120 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial

Dongsheng Yue, Wenxiang Wang, Hongxu Liu et al. · The Lancet Respiratory Medicine · 2024 · 110 citations

Medicine, Oncology, Surgery +16

Robot-assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma: Early Results of a Multicenter Randomized Controlled Trial: the RAMIE Trial.

Jun Yi, Rong Hua, Hezhong Chen et al. · PubMed · 2022 · 89 citations

Medicine, Perioperative Medicine, Surgery +13